Atıf Formatları
Polycythemia after vandetanib treatment in metastatic medullary thyroid carcinoma: A rare case report
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Y. İLHAN Et Al. , "Polycythemia after vandetanib treatment in metastatic medullary thyroid carcinoma: A rare case report," Current Problems in Cancer: Case Reports , 2020

İLHAN, Y. Et Al. 2020. Polycythemia after vandetanib treatment in metastatic medullary thyroid carcinoma: A rare case report. Current Problems in Cancer: Case Reports .

İLHAN, Y., COŞKUN, H. Ş., ATAŞ, Ü., & SEZGİN GÖKSU, S., (2020). Polycythemia after vandetanib treatment in metastatic medullary thyroid carcinoma: A rare case report. Current Problems in Cancer: Case Reports .

İLHAN, YUSUF Et Al. "Polycythemia after vandetanib treatment in metastatic medullary thyroid carcinoma: A rare case report," Current Problems in Cancer: Case Reports , 2020

İLHAN, YUSUF Et Al. "Polycythemia after vandetanib treatment in metastatic medullary thyroid carcinoma: A rare case report." Current Problems in Cancer: Case Reports , 2020

İLHAN, Y. Et Al. (2020) . "Polycythemia after vandetanib treatment in metastatic medullary thyroid carcinoma: A rare case report." Current Problems in Cancer: Case Reports .

@article{article, author={YUSUF İLHAN Et Al. }, title={Polycythemia after vandetanib treatment in metastatic medullary thyroid carcinoma: A rare case report}, journal={Current Problems in Cancer: Case Reports}, year=2020}